Garner Thomas's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 227,130 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Garner Thomas | SVP, Chief Commercial Officer | 08 Feb 2024 | 227,130 | 227,130 | - | - | Restricted Stock Units | ||
| Lexicon Pharmaceuticals Inc | Garner Thomas | SVP, Chief Commercial Officer | 08 Feb 2024 | 227,130 | 227,130 | - | - | Stock Option (Right to Buy) |